Now I have enough calibration data. Let me write the final consolidated review.

## Summary

This paper proposes a cross-validation method for graphon models (CV-imputation) that replaces held-out edges with Bernoulli random draws (parameter θ) instead of requiring matrix completion as in the existing Edge Cross-Validation (ECV) method. This avoids ECV's low-rank assumption and reduces per-fold computational complexity from O(n³) to O(n²). The authors provide Theorem 1 showing the CV score is asymptotically parallel to the true MSE, and evaluate across four synthetic graphons, four estimation methods (NS, SAS, USVT, ICE), and three real networks, plus a drug-disease co-occurrence case study.

## Strengths

1. **Avoids the low-rank assumption that limits ECV.** The Bernoulli-imputation scheme (Eq. 4, Lemma 1) works for full-rank graphons (e.g., Graphon 2 in Figure 2) where ECV's matrix-completion precondition fails. This is a principled advance over Li et al. (2020a).

2. **Asymptotic consistency guarantee (Theorem 1).** The paper proves that V_K(M) approximates L(M)+Λ uniformly, with the minimizer converging to the optimal model. Formal consistency is not provided for ECV, making this a genuine theoretical contribution.

3. **Real and substantial computational savings on large networks.** The complexity analysis (Section 3) correctly identifies the bottleneck: CV-imputation adds O(n²) per fold vs. ECV's O(T_mc(n)) (typically O(n³)). Table 2 confirms this with a striking 25× speedup on Yeast (240.9 s vs. 6021.12 s). These results are the most compelling evidence for the efficiency claim.

4. **Broad empirical scope.** The method is tested across 4 estimators × 4 graphons + 3 real networks + 1 case study. For most estimator–graphon combinations (NS, USVT, ICE), CV-imputation achieves substantially lower MSE than ECV (Table 1). The model-selection accuracy (Figure 5) is strong, reaching 100% at n=200.

5. **Plausible biological discovery in a real case study.** The COVID-19 drug-disease network analysis (Section 6.1) identifies a ledipasvir–COVID-19 link later corroborated by a Phase 3 trial, providing a concrete illustration of practical utility.

## Weaknesses

### Fatal
None.

### Major
- **The imputation parameter θ is not characterized in the main text.** The paper states (line 93) that θ "serves as a tuning parameter" and its selection is "discussed in Section S.4" (appendix, which is stripped). This means the method as presented in the main paper has an uncharacterized tuning parameter of its own, shifting rather than eliminating the tuning burden. Without knowing whether θ can be set to a universal constant (e.g., 0.5) or requires its own cross-validation loop, a reader cannot assess the method's practical reproducibility or whether the comparisons to ECV are fair. This is the most consequential gap in the submission.

### Minor
- **Improvements over ECV are marginal for the SAS estimator.** In Table 1, SAS results show CV-imputation vs. ECV differences well within one standard deviation (e.g., Graphon 1: 1.69±0.11 vs. 1.72±0.12; Graphon 2: 8.43±0.22 vs. 8.47±0.27; Graphon 3: 12.77±0.20 vs. 12.86±0.23). For NS on Graphon 3, the Default choice (M=1) gives lower MSE (0.74) than CV-imputation (0.79). The claim that CV-imputation "consistently selects models with smaller MSE" is overstated without qualification.

- **Value of K (number of folds) is not stated for any experiment.** The method section describes K-fold CV abstractly, but no experimental section reports what K was used. This is a basic reproducibility detail.

- **No statistical significance testing.** Table 1 reports means and standard deviations across 100 replicates, but no paired tests or effect sizes are provided to determine whether the observed differences are meaningful beyond sampling noise.

### Trivial
- "averaged over 100 replications" (Table 1 caption) — the paper uses "replications" where "replicates" is more standard, but this is not a content issue.
- "our method consistently outperforms ECV in terms of speed across all tested configurations" (line 203) — the extracted figure caption for Figure 3 contains contradictory alt-text ("In all cases, ECV is faster than CV-imputation"), which appears to be a PDF-extraction artifact (the figure itself likely uses correct labels, and the main text, complexity analysis, Figure 5, and Table 2 all support CV-imputation being faster).

## Nice-to-Haves
- A sensitivity analysis for θ over a range (e.g., 0.1–0.9) on at least one synthetic and one real dataset would address the θ-selection concern cleanly and strengthen the paper considerably.
- Reporting the variance of V_K(M) across folds would help assess the stability of the model selection procedure.
- Adding paired t-tests or Wilcoxon signed-rank tests for the key Table 1 comparisons would clarify which differences are statistically significant.

## Removed Points
- **Speed contradiction (Harsh Critic point 1):** The critic flags a contradiction between the main text and Figure 3's caption. The extracted alt-text says "ECV is faster than CV-imputation," but this is a PDF-parser artifact from the figure's embedded image label. The authored text (line 203), complexity analysis, Figure 5, and Table 2 all assert and support CV-imputation being faster. Per the formatting-artifact rule, this point is removed.
- **Condition 1 is too opaque (Harsh Critic point 3):** The critic claims verifying the polynomial rate is "nontrivial" and may be "as hard to check as the original problem." The paper does not claim it is cheap — only that it *can* be verified computationally, which is true. The paper provides an example (Erdős–Rényi, α=1) and states that validation is provided in Figure S.3. This is a speculative objection, not a concrete problem. Removed.
- **Default parameter comparison is misleading (Harsh Critic point 5):** The primary comparison is CV-imputation vs. ECV. The Default columns are clearly labeled secondary context showing why tuning matters, not a substitute for the ECV baseline. Removed.
- **Strength Finder's generic strengths ("important problem", "well-motivated"):** These are generic or sycophantic and removed per the filtering rules.

## Novel Insights
None beyond the paper's own contributions.

## Suggestions
1. Add a short paragraph in Section 3 specifying how θ was set in all experiments (e.g., a fixed value if universal, or the procedure from Section S.4). Include a sensitivity analysis across θ values for at least one synthetic and one real dataset.
2. Report the number of folds K used in all experiments and briefly discuss sensitivity to K.
3. Add statistical significance indicators (e.g., boldface for best, with paired t-test or Wilcoxon results) to Table 1.
4. Tone down the word "consistently" when comparing to ECV, and acknowledge the SAS and NS Graphon 3 cases explicitly, noting that the main empirical advantages come from NS, USVT, and ICE.

## Score and Decision

### Calibration Anchors

**Round 1 — Bracketing:**
| Paper | Path | Avg Score | Comparison |
|---|---|---|---|
| Intra-fused Gromov Wasserstein Discrepancy | .../Aku2I3z4aV.md | 2.60 | Much weaker — no clear method, poor evaluation |
| Random Graph Asymptotics for Treatment Effect | .../Ivk2j3uRYh.md | 4.50 | Weaker — limited novelty, largely applying existing methods |
| Exploring Edge Probability Graph Models | .../xljPZuprBA.md | 5.75 | Comparable — solid theory with some validation gaps |
| Invariant Graphon Networks | .../SjufxrSOYd.md | 8.00 | Much stronger — deep theory, clean results, unanimous high scores |

**Round 2 — Narrowing (bracket 4.5–6.5 → final):**
| Paper | Path | Avg Score | Comparison |
|---|---|---|---|
| DeepNT: Network Tomography | .../pQOHbTpAwf.md | 5.25 | Weaker — less theoretical grounding, narrower scope |
| Edge Dependency in Graph Generative Models | .../LCQ7YTzgRQ.md | 6.25 | Slightly stronger — tighter theory but also had validation/contribution concerns |
| Revisiting Link Prediction | .../8Ur2xmuw7w.md | 6.25 | Slightly stronger — accepted with interesting empirical findings |
| NetInfoF Framework | .../KY8ZNcljVU.md | 7.33 | Stronger — clearer practical impact, stronger theoretical-empirical link |

The paper sits between the 5.25 (DeepNT) and 5.75 (Edge Probability) anchors. It has a sound method, a formal consistency theorem, and a wide experimental scope — all points in its favor. But it is held back by the uncharacterized θ parameter (deferred to a stripped appendix), marginal improvements for SAS, and the absence of stated K and statistical tests. It is stronger than papers scoring ~5 with narrower contributions or weaker validation, but weaker than papers scoring ~6+ that present tighter, more self-contained arguments.

### Initial bracket: 4.5–6.5
### Final score determination: The paper is closest to the 5.5–5.75 range. The θ gap is a real weakness that prevents a higher score, but the core contribution is solid enough to place it above the 5.0-level papers.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>